Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Shpall, Elizabeth J  [Clear All Filters]
2016
Langman, L.J., Nesher, L., Shah, D.P., Azzi, J.M., Shpall, E.J., Rezvani, K., Black, J.L., and Chemaly, R.F. (2016). Challenges in Determining Genotypes for Pharmacogenetics in Allogeneic Hematopoietic Cell Transplant Recipients.J Mol Diagn.
Nieto, Y., Valdez, B.C., Thall, P.F., Jones, R.B., Wei, W., Myers, A., Hosing, C., Ahmed, S., Popat, U., Shpall, E.J., et al. (2016). Double epigenetic modulation of high-dose chemotherapy with azacitidine and vorinostat for patients with refractory or poor-risk relapsed lymphoma.Cancer.
Ma, Q., Garber, H.R., Lu, S., He, H., Tallis, E., Ding, X., Sergeeva, A., Wood, M.S., Dotti, G., Salvado, B., et al. (2016). A novel TCR-like CAR with specificity for PR1/HLA-A2 effectively targets myeloid leukemia in vitro when expressed in human adult peripheral blood and cord blood T cells.Cytotherapy.
Kebriaei, P., Singh, H., M Huls, H., Figliola, M.J., Bassett, R., Olivares, S., Jena, B., Dawson, M.J., Kumaresan, P.R., Su, S., et al. (2016). Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells.J Clin Invest.
Aung, F.M., Lichtiger, B., Rondon, G., C Yin, C., Alousi, A., Ahmed, S., Andersson, B., Bashier, Q., Ciurea, S.O., Hosing, C., et al. (2016). Pure Red Cell Aplasia in Major ABO Mismatched Allogeneic Hematopoietic Stem Cell Transplantation is Associated with Severe Pancytopenia.Biol Blood Marrow Transplant.
Gaballa, S., Ge, I., Fakih, R.El, Brammer, J.E., Kongtim, P., Tomuleasa, C., Wang, S.A., Lee, D., Petropoulos, D., Cao, K., et al. (2016). Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation.Cancer.
2013
Shah, N., Martin-Antonio, B., Yang, H., Ku, S., Lee, D.A., Cooper, L.J.N., Decker, W.K., Li, S., Robinson, S.N., Sekine, T., et al. (2013). Antigen presenting cell-mediated expansion of human umbilical cord blood yields log-scale expansion of natural killer cells with anti-myeloma activity.Plos One8, e76781.
Hart, J.W., Shiue, L.H., Shpall, E.J., and Alousi, A.M. (2013). Extracorporeal photopheresis in the treatment of graft-versus-host disease: evidence and opinion.Ther Adv Hematol4, 320-334.
Bayraktar, U.D., Shpall, E.J., Liu, P., Ciurea, S.O., Rondon, G., de Lima, M., Cardenas-Turanzas, M., Price, K.J., Champlin, R.E., and Nates, J.L. (2013). Hematopoietic Cell Transplantation-Specific Comorbidity Index Predicts Inpatient Mortality and Survival in Patients Who Received Allogeneic Transplantation Admitted to the Intensive Care Unit.J Clin Oncol.
Russell Y Cruz, C., Micklethwaite, K.P., Savoldo, B., Ramos, C.A., Lam, S., Ku, S., Diouf, O., Liu, E., A Barrett, J., Ito, S., et al. (2013). Infusion of donor-derived CD19-redirected-virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase I study.Blood.
Leen, A.M., Bollard, C.M., Mendizabal, A.M., Shpall, E.J., Szabolcs, P., Antin, J.H., Kapoor, N., Pai, S.-Y., Rowley, S.D., Kebriaei, P., et al. (2013). Multicenter study of banked third party virus-specific T-cells to treat severe viral infections after hematopoietic stem cell transplantation.Blood.